Company / Current Assets
RHYTHM PHARMACEUTICALS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$466.9M
FY2025
5-year range
$308.3M / $466.9M
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#121 of 213
Health Care
What the data says
At $467M, RHYTHM PHARMACEUTICALS, INC.'s current assets ranks #121 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $11M in FY2016 to $467M in FY2025.
Based on SEC 10-K filings.
$467M in FY2025 with a 5-year CAGR of +20.8%.
Improved from $308M to $467M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
#121 of 213 in Health CareTop 57% of 213This company $466.9M Sector average $2.5B
▼
-81.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.8%, indicating consistent growth.
- In FY2025, current assets increased 24.8% year-over-year.
- Ranks #121 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $466.9M | +24.8% |
| FY2024 | $374.2M | +21.4% |
| FY2023 | $308.3M | -13.0% |
| FY2022 | $354.2M | +14.9% |
| FY2021 | $308.4M | +69.8% |
| FY2020 | $181.7M | -39.9% |
| FY2019 | $302.4M | +16.9% |
| FY2018 | $258.7M | +71.7% |
| FY2017 | $150.7M | +1248.3% |
| FY2016 | $11.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026